Haleon HLN
NYSE HLN
$9.88 +0.01 (+0.05%)
At close: Aug 20, 2026 · 2:05 PM UTC

Haleon (HLN) Depreciation and Depletion (2022 - 2025)

Haleon's (HLN) quarterly Depreciation and Depletion came in at $154.1 million in Q4 2025, up 26.67% on a QoQ basis from $121.6 million in Q4 2023.

Haleon (HLN) Depreciation and Depletion (2022 - 2025) Analysis & Trends

Haleon (HLN) has 3 years of Depreciation and Depletion data on file, last reported at $154.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 154.08 Mn
Dec 31, 2025 154.08 Mn
Dec 31, 2023 121.63 Mn
Dec 31, 2023 121.63 Mn
Dec 31, 2022 96.18 Mn
Dec 31, 2022 96.18 Mn